المؤلفون: John Wilding, Thomas Godec, Kamlesh Khunti, Stuart Pocock, Robin Fox, Liam Smeeth, Per Clauson, Peter Fenici, Niklas Hammar, Jesús Medina

المصدر: BMC Medicine, Vol 16, Iss 1, Pp 1-12 (2018)

مصطلحات موضوعية: Clinical practice research datalink (CPRD), Dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor), HbA1c, Metformin, Second-line therapy, Sodium-glucose cotransporter 2 inhibitor (SGLT-2 inhibitor), Medicine

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s12916-018-1085-8Test; https://doaj.org/toc/1741-7015Test

الوصول الحر: https://doaj.org/article/7ebfc4fe14464ddf82451f2fd37841f9Test

المؤلفون: Raffaele Marfella, Celestino Sardu, Nunzia D’Onofrio, Carlo Fumagalli, Lucia Scisciola, Ferdinando Carlo Sasso, Mario Siniscalchi, Ludovica Vittoria Marfella, Davide D’Andrea, Fabio Minicucci, Giuseppe Signoriello, Arturo Cesaro, Maria Consiglia Trotta, Chiara Frigé, Francesco Prattichizzo, Maria Luisa Balestrieri, Antonio Ceriello, Paolo Calabrò, Ciro Mauro, Luca del Viscovo, Giuseppe Paolisso

المساهمون: Marfella, Raffaele, Sardu, Celestino, D'Onofrio, Nunzia, Fumagalli, Carlo, Scisciola, Lucia, Sasso, Ferdinando Carlo, Siniscalchi, Mario, Marfella, Ludovica Vittoria, D'Andrea, Davide, Minicucci, Fabio, Signoriello, Giuseppe, Cesaro, Arturo, Trotta, Maria Consiglia, Frigé, Chiara, Prattichizzo, Francesco, Balestrieri, Maria Luisa, Ceriello, Antonio, Calabrò, Paolo, Mauro, Ciro, Del Viscovo, Luca, Paolisso, Giuseppe

المصدر: BMC Medicine. 21

مصطلحات موضوعية: Glycemic control, Major adverse cardiovascular event, SGLT-2 inhibitor, Restenosi, Type 2 diabetes, General Medicine

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0c0c14a33596021f97417e2b0105916Test
https://doi.org/10.1186/s12916-023-02781-2Test

المؤلفون: Kamlesh Khunti, Per Clauson, Stuart J. Pocock, Peter Fenici, Niklas Hammar, Robin Fox, Jesús Medina, Thomas Godec, Liam Smeeth, John P.H. Wilding

المصدر: BMC Medicine
BMC Medicine, Vol 16, Iss 1, Pp 1-12 (2018)

مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, HbA1c, endocrine system diseases, medicine.drug_class, Population, lcsh:Medicine, Sodium-glucose cotransporter 2 inhibitor (SGLT-2 inhibitor), 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor), Sulfonylurea, Weight loss, Internal medicine, medicine, Humans, Hypoglycemic Agents, Type 2 diabetes (T2D), education, Glycated Hemoglobin, education.field_of_study, business.industry, lcsh:R, Body Weight, nutritional and metabolic diseases, General Medicine, Middle Aged, medicine.disease, Metformin, United Kingdom, Clinical practice research datalink (CPRD), 3. Good health, Discontinuation, Standard error, Diabetes Mellitus, Type 2, Cohort, Female, medicine.symptom, business, Second-line therapy, Research Article, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee4d3e5096970425220299402f5d2effTest
https://doi.org/10.1186/s12916-018-1085-8Test